Bernardo Wealth Planning’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bernardo Wealth Planning’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-78,578	Closed	-$25.6K	–	94
2023 Q2	$25.6K	Buy	78,578 +40,000	+104%	+$14.3K	0.01%	90
2023 Q1	$16.6K	Hold	38,578	–	–	0.01%	90
2022 Q4	$20.4K	Buy	38,578 +8,109	+27%	+$5.14K	0.01%	88
2022 Q3	$20K	Hold	30,469	–	–	0.01%	81
2022 Q2	$34K	Hold	30,469	–	–	0.02%	82
2022 Q1	$62K	Hold	30,469	–	–	0.03%	89
2021 Q4	$87K	Buy	30,469 +1,650	+6%	+$6.1K	0.04%	85
2021 Q3	$122K	Buy	28,819 +1,600	+6%	+$7.14K	0.07%	76
2021 Q2	$143K	Hold	27,219	–	–	0.09%	76
2021 Q1	$126K	Hold	27,219	–	–	0.08%	75
2020 Q4	$89K	Hold	27,219	–	–	0.03%	171
2020 Q3	$90K	Buy	27,219 +800	+3%	+$2.94K	0.04%	154
2020 Q2	$89K	Hold	26,419	–	–	0.05%	137
2020 Q1	$101K	Hold	26,419	–	–	0.07%	130
2019 Q4	$159K	Hold	26,419	–	–	0.1%	160
2019 Q3	$199K	Hold	26,419	–	–	0.14%	152
2019 Q2	$358K	Buy	26,419 +1,000	+4%	+$11.5K	0.28%	99
2019 Q1	$138K	Buy	25,419 +1,278	+5%	+$6.22K	0.11%	145
2018 Q4	$72K	Buy	+24,141	New	+$132K	0.06%	130

Other funds holding ZYNE

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bernardo Wealth Planning's ZYNE Position: Q3 2023 in Review

Bernardo Wealth Planning sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2023, closing a stake of 78,578 shares — an estimated $25.6K sold.

Bernardo Wealth Planning first reported a position in ZYNE in Q4 2018 and held it in 19 quarters. The position peaked at $358K in Q2 2019. 43 funds tracked by Wall St. Rank hold ZYNE as of Q3 2023.

Bernardo Wealth Planning reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2023 after selling out during the quarter.
Bernardo Wealth Planning sold 78,578 Zynerba Pharmaceuticals, Inc shares in Q3 2023, an estimated $25.6K.
Bernardo Wealth Planning first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2018 and held it in 19 quarters.
Bernardo Wealth Planning's Zynerba Pharmaceuticals, Inc position peaked at $358K in Q2 2019.
43 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2023.

Based on Bernardo Wealth Planning's 13F filing for Q3 2023, filed 30 Oct 2023.